Studio E: The Epilepsy Art Program
Studio E offers group therapy sessions for adults living with epilepsy, allowing them to explore their creativity, meet others with epilepsy and express themselves in an open, accepting and safe group setting.
During the program, partcipants work with art professionals using a variety of artistic media, including painting, sketching, and sculpting. Because some things are easier to “say” through art, Studio E provides people impacted by epilepsy a unique opportunity to express themselves and open up about their experiences with the condition.
Studio E artwork will help raise awareness about the realities of life with epilepsy. To view artwork created at previous session, please visit our Studio E: The Epilepsy Art Program Gallery.
Studio E Sessions
Drop-in Sessions (for adults):
The Epilepsy Foundation of Greater Chicago is excited to offer adults living with epilepsy the opportunity to attend monthly Studio E Drop-in Sessions from 12:00-3:00 pm at our downtown office (Suite 820) at 17 N. State St. in Chicago, beginning Monday, September 10, 2018 and concluding Monday, July 8, 2019. (Note: There will be no sessions in August, January, and February).
Materials and guidance for art and writing will be provided in a relaxed environment where creative expression and conversation are welcomed. Expressive Writing workshops are incorporated in the monthly Drop-In Sessions. No prior experience with art or writing in needed. Come to as many sessions as you like, all free of charge.
Monday, September 10, 2018
Monday, October 1, 2018
Monday, November 5, 2018
Monday, December 10, 2018
Monday, March 11, 2018
Monday, April 8, 2019
Monday, May 13, 2018
Monday, June 10, 2018
Monday, July 8 , 2018
Return completed forms to Crissy Catalano –
Epilepsy Foundation of Greater Chicago
Attn: Crissy Catalano
17 N. State St., Suite 650
For more information, contact Crissy at email@example.com or 312-939-8622 ext 211.
Studio E is offered for free thanks to the generous support of our partners, Lundbeck and OWP Pharma/ROW Foundation, and supported in memory of Sally Ruark.